Snap-8 20mg (10 Vials/kit): Octapeptide SNARE Complex Inhibitor for Neuromuscular & Biomimetic Research

Snap-8 (Acetyl Octapeptide-3 / Acetyl Glutamyl Heptapeptide-1) is a elongated synthetic octapeptide derivative engineered to mimic the N-terminal end of SNAP-25 (Synaptosomal-Associated Protein 25). Designed as an advanced evolution of Argireline (Acetyl Hexapeptide-8), Snap-8 features an extended sequence ($\text{Ac-Glu-Glu-Met-Gln-Arg-Arg-Ala-Asp-NH}_2$) that competitively binds to the ternary SNARE (Soluble N-ethylmaleimide-sensitive factor Attachment Protein Receptor) complex. In neuromuscular junction and cell membrane models, Snap-8 destabilizes SNARE assembly, suppressing Ca²⁺-dependent exocytosis of acetylcholine ($\text{ACh}$) and catecholamines. Sourcing Snap-8 20mg (10 vials/kit) provides biochemistry laboratories, dermatological research teams, and molecular pharmacologists with a high-purity biomimetic reagent to investigate muscle contraction inhibition, synaptic vesicle fusion, and facial line modulation in vitro and ex vivo.

At the cellular level, neurotransmitter release requires the assembly of a stable core SNARE complex comprising SNAP-25, Syntaxin, and Synaptobrevin (VAMP). By mimicking the amino acid sequence of native SNAP-25, Snap-8 competitively displaces native SNAP-25 during complex formation. This yields an incompetent, truncated SNARE assembly that cannot complete membrane fusion:

In comparative bioactivity assays, Snap-8 demonstrates up to approximately 30% greater potency in inhibiting catecholamine release and micro-muscle twitching relative to shorter hexapeptide analogs, making it a critical reference compound for anti-wrinkle peptide mechanics and neuro-muscular signaling research.

The Snap-8 20mg (10 vials/kit) configuration yields a high-capacity kit payload of 200mg total active peptide material (20mg per vial across ten individual USP Type I borosilicate glass vials). Freeze-dried under sterile vacuum conditions, each vial contains a uniform, highly stable lyophilized cake. This multi-vial arrangement ensures researchers can prepare single 20mg working solutions for specific assay series while keeping remaining inventory preserved under vacuum seal to prevent ambient humidity absorption or chemical hydrolysis.

SNARE Disruption Mechanics, Biomimetic Potency, and Technical Profile

The primary scientific value of Snap-8 20mg (10 vials/kit) lies in its extended sequence length, competitive receptor antagonism, and verified stability profile:

• Competitive SNAP-25 Antagonism: Competes directly with native SNAP-25 for binding sites within the SNARE core complex, inhibiting functional complex assembly.

• Attenuated Exocytosis: Suppresses calcium ion ($\text{Ca}^{2+}$)-triggered vesicular release of acetylcholine ($\text{ACh}$) at pre-synaptic membranes without cell cytotoxicity.

• Superior Biomimetic Activity: Extended 8-amino-acid chain provides increased steric binding affinity relative to standard hexapeptides like Argireline.

• Neuromuscular & Cosmetic Cell Models: Ideal for evaluating cutaneous micro-tension, dermal matrix longevity, and topical delivery carrier formulations in modern cosmeceutical screening.

• Ultra-High Chemical Purity ($\ge$99.0%): Manufactured via automated Solid-Phase Peptide Synthesis ($\text{SPPS}$) and purified using preparative High-Performance Liquid Chromatography ($\text{HPLC}$) to ensure complete removal of deletion sequences and synthesis byproducts.

Reconstitution Guidelines, Laboratory Storage Standards, and Quality Protocols

Achieving reproducible, publication-grade results when working with Snap-8 20mg (10 vials/kit) requires strict adherence to standardized laboratory preparation and climate-controlled storage protocols.

Perform all reconstitution procedures inside a certified Class II Biosafety Cabinet:

1. Temperature Balancing: Allow the frozen Snap-8 vial to adjust to ambient room temperature prior to solvent introduction to eliminate moisture condensation inside the glass container.

2. Septum Sanitization: Remove the protective plastic flip-cap and thoroughly wipe the synthetic rubber stopper with a fresh 70% isopropyl alcohol pad. Allow the surface to dry completely.

3. Slow Diluent Addition: Using a sterile syringe equipped with a fine-gauge needle, draw the required volume of Sterile Water, Normal Saline (0.9% NaCl), or Phosphate-Buffered Saline (PBS). Direct the liquid stream against the inner glass wall so it trickles slowly over the lyophilized cake.

4. Gentle Hydration: Allow the diluent to fully hydrate the powder cake for 2 minutes. Gently roll the vial between your palms or swirl in smooth circular motions until clear. Never vortex or shake violently, as high-shear agitation can disrupt peptide secondary structures and induce protein foaming.

5. Micro-Aliquot Strategy: For multi-week testing protocols, divide reconstituted liquid into sterile, single-use microcentrifuge tubes under aseptic conditions to prevent atmospheric oxidation and eliminate repeated freeze-thaw cycles.

Batch Quality Documentation & Traceability: Every production lot of Snap-8 20mg (10 vials/kit) undergoes third-party analytical testing. High-Performance Liquid Chromatography (HPLC) chromatograms confirm component purity exceeding 99.0%, while Electrospray Ionization Mass Spectrometry (ESI-MS) confirms precise theoretical molecular mass. Each shipment includes a batch-specific Certificate of Analysis (COA) documenting chemical purity, residual solvent analysis, heavy metal screens, and bacterial endotoxin levels (<0.05 EU/mg) to satisfy institutional compliance requirements.

Strict Regulatory & Research Compliance Statement: Snap-8 20mg (10 vials/kit) is produced, packaged, and distributed exclusively for in vitro laboratory research, academic experimentation, chemical synthesis, and preclinical research. Snap-8 20mg (10 vials/kit) is strictly not intended, formulated, or approved for human or animal consumption, therapeutic medical treatment, clinical diagnostic work, or cosmetic applications. All handling must be conducted by certified research personnel operating within equipped laboratory facilities in compliance with OSHA workplace safety regulations and institutional biosafety protocols.